Amberstone Biosciences and Henlius Enter into Collaboration and License Agreement for Conditionally Activated T-Cell Engagers for Solid Tumors

Summary

Amberstone Biosciences entered into a collaboration and license agreement with Shanghai Henlius Biotech for pH-gated, tumor-activated T-cell engagers targeting solid tumors.